Skip to main content

Table 5 Frequency distribution of all adverse events reported after surgery

From: Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction

  Dose level  
Event 1 2 3 Total
Number of patients 3 (100%) 11 (100%) 4 (100%) 18 (100%)
 Any event 1 (33%) 2 (18%) 1 (25%) 4 (22%)
 Pericardial effusion    1 (25%) 1 (6%)
 Fever 1 (33%)    1 (6%)
 Infection   1 (9%)   1 (6%)
 Pleural effusion   1 (9%)   1 (6%)